Sidra FNU, Agarwal S, Lockhart Pastor P, Xie D, et al. Glucagon-like Peptide-1 receptor agonists versus dipeptidyl-peptidase 4 inhibitors in advanced chronic kidney disease and end stage kidney disease: Real world effectiveness and persistence of therapy. J Diabetes Complications 2025;39:108925.
PMID: 39644537